rabbit polyclonal anti ae1 Search Results


93
Proteintech rabbit anti band 3 antibody
Rabbit Anti Band 3 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/band+3%2F+AE1+Antibody/pmc06236465-76-25-29
Average 93 stars, based on 1 article reviews
rabbit anti band 3 antibody - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
Novus Biologicals pan cytokeratin
Pan Cytokeratin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/Cytokeratin%2C+pan+Antibody+(AE-1%2FAE-3)/bio_rxiv__64898__2026__04__02__716182-297-32-36
Average 94 stars, based on 1 article reviews
pan cytokeratin - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
fluidigm antibody pan cytokeratin
Antibody Pan Cytokeratin, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/Anti-Pan-Cytokeratin+(AE1%2FAE3)-148Nd/10__7554_slash_elife__78921-32-149-155
Average 93 stars, based on 1 article reviews
antibody pan cytokeratin - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse monoclonal anti pan cytokeratin ae1 ae3
Mouse Monoclonal Anti Pan Cytokeratin Ae1 Ae3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/pan-Cytokeratin+Antibody/pmc03325228-159-52-57
Average 96 stars, based on 1 article reviews
mouse monoclonal anti pan cytokeratin ae1 ae3 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Novus Biologicals mouse anti pan cytokeratin
Mouse Anti Pan Cytokeratin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/Cytokeratin%2C+pan+Antibody+(AE-1%2FAE-3)/pmc08406534-427-9-11
Average 95 stars, based on 1 article reviews
mouse anti pan cytokeratin - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

92
Novus Biologicals mouse anti pancytokeratin
Mouse Anti Pancytokeratin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/Cytokeratin%2C+Acidic+(Type+I+or+LMW)+Antibody+(AE1)+%5BmFluor+Violet+450+SE%5D/10__1172_slash_jci176402-301-0-4
Average 92 stars, based on 1 article reviews
mouse anti pancytokeratin - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

88
Thermo Fisher gene exp adgrf5 mm00685646 m1
<t>Gpr116</t> is highly expressed in kidney and is localized to V-ATPase expressing ICs of the collecting duct. (A) Gpr116 mRNA expression as measured by qRT-PCR in various tissues including lung and kidney. SP-C and AQP2 served as positive controls of lung and kidney mRNA. Gene expression is normalized to Gapdh. Cycle threshold of 35 approximately corresponds with 0.001 on the y axis. (B) Western blot analysis of Gpr116 expression in various tissues as well as stably transfected HEK293 cells with mouse (mGpr116) or human (hGpr116) Gpr116. Expected molecular mass for Gpr116 is ∼150 kDa. (C) Diagram of the murine outer medullary collecting duct (OMCD) showing water-transporting principal cells (PC) and acid-secreting A-IC. Proton secretion is coupled to bicarbonate reabsorption throughout the nephron. (D) Representative immunofluorescence images demonstrating colocalization of Gpr116 with V-ATPase in mouse collecting ducts. Similarly, Gpr116 is interspersed among AQP2 expressing cells in mouse collecting ducts. (Scale bars, 20 μm.)
Gene Exp Adgrf5 Mm00685646 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/Anti+Gene+Exp%2E+Adgrf5%2C+Mm00685646_m1/pmc07584995-447-21--1
Average 88 stars, based on 1 article reviews
gene exp adgrf5 mm00685646 m1 - by Bioz Stars, 2026-10
88/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc anti foxp3
AhR expression and localization in the TME of bladder, colorectal, esophageal, head and neck, and non-small cell lung cancers. (A) Scheme of the workflow used for generating AhR expression data from five FFPE TMA slides: NSCLC (non-small cell lung cancer, N = 98), HNSCC (head and neck squamous cell carcinoma, N = 80), CRC (colorectal cancer, N = 97), EC (esophageal cancer, N = 190), and BLCA (bladder cancer, N = 48). Prior to cell segmentation and tissue segmentation using the deep-learning inForm algorithm, five TMA slides were stained with six antibodies, DAPI, and anti-AhR, -CD68, -CD4, -CD8, -Pan-CK, and <t>-FoxP3,</t> using Vectra Polaris for mIHC image generation. The resulting data were manipulated to perform image cytometry for phenotyping and AhR expression analysis. (B) Representative mIHC image of the region of interest stained with six antibodies: DAPI for nucleus, Pan-CK for cancer/epithelial cells, CD4 and CD8 for T cells, CD68 for macrophages, and FoxP3 for Tregs. (C) Heatmap summarizing the AhR expression in five different tissue samples: NSCLC, HNSCC, colorectal cancer, esophageal cancer, and bladder cancer. The resulting data were clustered based on the AhR expression in the cytosol or nucleus of cancer/epithelial cells, T cells, macrophages, and Tregs. (D) Pie charts depicting the AhR-positive (AhR + ) and -negative (AhR - ) cancer cells (left) and average percentage of AhR-expressing cancer cells (right) in the cytosol and nucleus of NSCLC, HNSCC, CRC (colorectal cancer), EC (esophageal cancer), and BLCA (bladder cancer) cells.
Anti Foxp3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/FoxP3+Rabbit+mAb/pmc11045933-74-30-33
Average 96 stars, based on 1 article reviews
anti foxp3 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

99
Danaher Inc mouse anti ae 1 3
AhR expression and localization in the TME of bladder, colorectal, esophageal, head and neck, and non-small cell lung cancers. (A) Scheme of the workflow used for generating AhR expression data from five FFPE TMA slides: NSCLC (non-small cell lung cancer, N = 98), HNSCC (head and neck squamous cell carcinoma, N = 80), CRC (colorectal cancer, N = 97), EC (esophageal cancer, N = 190), and BLCA (bladder cancer, N = 48). Prior to cell segmentation and tissue segmentation using the deep-learning inForm algorithm, five TMA slides were stained with six antibodies, DAPI, and anti-AhR, -CD68, -CD4, -CD8, -Pan-CK, and <t>-FoxP3,</t> using Vectra Polaris for mIHC image generation. The resulting data were manipulated to perform image cytometry for phenotyping and AhR expression analysis. (B) Representative mIHC image of the region of interest stained with six antibodies: DAPI for nucleus, Pan-CK for cancer/epithelial cells, CD4 and CD8 for T cells, CD68 for macrophages, and FoxP3 for Tregs. (C) Heatmap summarizing the AhR expression in five different tissue samples: NSCLC, HNSCC, colorectal cancer, esophageal cancer, and bladder cancer. The resulting data were clustered based on the AhR expression in the cytosol or nucleus of cancer/epithelial cells, T cells, macrophages, and Tregs. (D) Pie charts depicting the AhR-positive (AhR + ) and -negative (AhR - ) cancer cells (left) and average percentage of AhR-expressing cancer cells (right) in the cytosol and nucleus of NSCLC, HNSCC, CRC (colorectal cancer), EC (esophageal cancer), and BLCA (bladder cancer) cells.
Mouse Anti Ae 1 3, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/mouse+monoclonal+Anti-SOX2+antibody/pmc08305380-73-9-12
Average 99 stars, based on 1 article reviews
mouse anti ae 1 3 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

93
Novus Biologicals mouse anti cytokeratin antibody
AhR expression and localization in the TME of bladder, colorectal, esophageal, head and neck, and non-small cell lung cancers. (A) Scheme of the workflow used for generating AhR expression data from five FFPE TMA slides: NSCLC (non-small cell lung cancer, N = 98), HNSCC (head and neck squamous cell carcinoma, N = 80), CRC (colorectal cancer, N = 97), EC (esophageal cancer, N = 190), and BLCA (bladder cancer, N = 48). Prior to cell segmentation and tissue segmentation using the deep-learning inForm algorithm, five TMA slides were stained with six antibodies, DAPI, and anti-AhR, -CD68, -CD4, -CD8, -Pan-CK, and <t>-FoxP3,</t> using Vectra Polaris for mIHC image generation. The resulting data were manipulated to perform image cytometry for phenotyping and AhR expression analysis. (B) Representative mIHC image of the region of interest stained with six antibodies: DAPI for nucleus, Pan-CK for cancer/epithelial cells, CD4 and CD8 for T cells, CD68 for macrophages, and FoxP3 for Tregs. (C) Heatmap summarizing the AhR expression in five different tissue samples: NSCLC, HNSCC, colorectal cancer, esophageal cancer, and bladder cancer. The resulting data were clustered based on the AhR expression in the cytosol or nucleus of cancer/epithelial cells, T cells, macrophages, and Tregs. (D) Pie charts depicting the AhR-positive (AhR + ) and -negative (AhR - ) cancer cells (left) and average percentage of AhR-expressing cancer cells (right) in the cytosol and nucleus of NSCLC, HNSCC, CRC (colorectal cancer), EC (esophageal cancer), and BLCA (bladder cancer) cells.
Mouse Anti Cytokeratin Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/Cytokeratin%2C+Acidic+(Type+I+or+LMW)+Antibody+(AE1)/10__21203_slash_rs__3__rs___6575028_slash_v1-158-92-98
Average 93 stars, based on 1 article reviews
mouse anti cytokeratin antibody - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc rabbit anti ae1 20112
AhR expression and localization in the TME of bladder, colorectal, esophageal, head and neck, and non-small cell lung cancers. (A) Scheme of the workflow used for generating AhR expression data from five FFPE TMA slides: NSCLC (non-small cell lung cancer, N = 98), HNSCC (head and neck squamous cell carcinoma, N = 80), CRC (colorectal cancer, N = 97), EC (esophageal cancer, N = 190), and BLCA (bladder cancer, N = 48). Prior to cell segmentation and tissue segmentation using the deep-learning inForm algorithm, five TMA slides were stained with six antibodies, DAPI, and anti-AhR, -CD68, -CD4, -CD8, -Pan-CK, and <t>-FoxP3,</t> using Vectra Polaris for mIHC image generation. The resulting data were manipulated to perform image cytometry for phenotyping and AhR expression analysis. (B) Representative mIHC image of the region of interest stained with six antibodies: DAPI for nucleus, Pan-CK for cancer/epithelial cells, CD4 and CD8 for T cells, CD68 for macrophages, and FoxP3 for Tregs. (C) Heatmap summarizing the AhR expression in five different tissue samples: NSCLC, HNSCC, colorectal cancer, esophageal cancer, and bladder cancer. The resulting data were clustered based on the AhR expression in the cytosol or nucleus of cancer/epithelial cells, T cells, macrophages, and Tregs. (D) Pie charts depicting the AhR-positive (AhR + ) and -negative (AhR - ) cancer cells (left) and average percentage of AhR-expressing cancer cells (right) in the cytosol and nucleus of NSCLC, HNSCC, CRC (colorectal cancer), EC (esophageal cancer), and BLCA (bladder cancer) cells.
Rabbit Anti Ae1 20112, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/AE1%2FSLC4A1+Rabbit+mAb/bio_rxiv__2023__10__12__562078-41-20-24
Average 93 stars, based on 1 article reviews
rabbit anti ae1 20112 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Novus Biologicals mouse anti human pan ck
AhR expression and localization in the TME of bladder, colorectal, esophageal, head and neck, and non-small cell lung cancers. (A) Scheme of the workflow used for generating AhR expression data from five FFPE TMA slides: NSCLC (non-small cell lung cancer, N = 98), HNSCC (head and neck squamous cell carcinoma, N = 80), CRC (colorectal cancer, N = 97), EC (esophageal cancer, N = 190), and BLCA (bladder cancer, N = 48). Prior to cell segmentation and tissue segmentation using the deep-learning inForm algorithm, five TMA slides were stained with six antibodies, DAPI, and anti-AhR, -CD68, -CD4, -CD8, -Pan-CK, and <t>-FoxP3,</t> using Vectra Polaris for mIHC image generation. The resulting data were manipulated to perform image cytometry for phenotyping and AhR expression analysis. (B) Representative mIHC image of the region of interest stained with six antibodies: DAPI for nucleus, Pan-CK for cancer/epithelial cells, CD4 and CD8 for T cells, CD68 for macrophages, and FoxP3 for Tregs. (C) Heatmap summarizing the AhR expression in five different tissue samples: NSCLC, HNSCC, colorectal cancer, esophageal cancer, and bladder cancer. The resulting data were clustered based on the AhR expression in the cytosol or nucleus of cancer/epithelial cells, T cells, macrophages, and Tregs. (D) Pie charts depicting the AhR-positive (AhR + ) and -negative (AhR - ) cancer cells (left) and average percentage of AhR-expressing cancer cells (right) in the cytosol and nucleus of NSCLC, HNSCC, CRC (colorectal cancer), EC (esophageal cancer), and BLCA (bladder cancer) cells.
Mouse Anti Human Pan Ck, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+ae1/Cytokeratin%2C+pan+Antibody+(AE-1%2FAE-3)+%5BAlexa+Fluor%C2%AE+647%5D/ppr0717259-83-32-35
Average 93 stars, based on 1 article reviews
mouse anti human pan ck - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


Gpr116 is highly expressed in kidney and is localized to V-ATPase expressing ICs of the collecting duct. (A) Gpr116 mRNA expression as measured by qRT-PCR in various tissues including lung and kidney. SP-C and AQP2 served as positive controls of lung and kidney mRNA. Gene expression is normalized to Gapdh. Cycle threshold of 35 approximately corresponds with 0.001 on the y axis. (B) Western blot analysis of Gpr116 expression in various tissues as well as stably transfected HEK293 cells with mouse (mGpr116) or human (hGpr116) Gpr116. Expected molecular mass for Gpr116 is ∼150 kDa. (C) Diagram of the murine outer medullary collecting duct (OMCD) showing water-transporting principal cells (PC) and acid-secreting A-IC. Proton secretion is coupled to bicarbonate reabsorption throughout the nephron. (D) Representative immunofluorescence images demonstrating colocalization of Gpr116 with V-ATPase in mouse collecting ducts. Similarly, Gpr116 is interspersed among AQP2 expressing cells in mouse collecting ducts. (Scale bars, 20 μm.)

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion

doi: 10.1073/pnas.2007620117

Figure Lengend Snippet: Gpr116 is highly expressed in kidney and is localized to V-ATPase expressing ICs of the collecting duct. (A) Gpr116 mRNA expression as measured by qRT-PCR in various tissues including lung and kidney. SP-C and AQP2 served as positive controls of lung and kidney mRNA. Gene expression is normalized to Gapdh. Cycle threshold of 35 approximately corresponds with 0.001 on the y axis. (B) Western blot analysis of Gpr116 expression in various tissues as well as stably transfected HEK293 cells with mouse (mGpr116) or human (hGpr116) Gpr116. Expected molecular mass for Gpr116 is ∼150 kDa. (C) Diagram of the murine outer medullary collecting duct (OMCD) showing water-transporting principal cells (PC) and acid-secreting A-IC. Proton secretion is coupled to bicarbonate reabsorption throughout the nephron. (D) Representative immunofluorescence images demonstrating colocalization of Gpr116 with V-ATPase in mouse collecting ducts. Similarly, Gpr116 is interspersed among AQP2 expressing cells in mouse collecting ducts. (Scale bars, 20 μm.)

Article Snippet: Antibodies used in the study table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene TaqMan ID Exon boundary ADGRF5 (Gpr116) Mm00685646_m1 6–7 SFTPC (SP-C) Mm00488144_m1 1–2 AQP2 Mm00437575_m1 1–2 SLC4A1 (AE1) Mm00441492_m1 3–4 ATP6V1B1 Mm00460309_m1 2–3 ATP6V0D2 Mm01222963_m1 1–2 ATP6V1G3 Mm00616840_m1 2–3 AQP6 Mm00558232_m1 1–2 CLCN5 (ClC-5) Mm00443851_m1 8–9 Open in a separate window TaqMan real-time PCR assays used

Techniques: Expressing, Quantitative RT-PCR, Gene Expression, Western Blot, Stable Transfection, Transfection, Immunofluorescence

Gpr116 activation by exogenous synthetic agonist peptide mobilizes calcium in vitro and in split-open cortical collecting ducts. (A–E) Stimulation of heterologous murine and human Gpr116 in HEK293 cells with p16 synthetic agonist peptide (200 μM), but not with the control peptide (F3A), causes an increase in [Ca2+]i as measured by ΔF340/F380. Nontransfected control is shown in E. In A and C, traces are the mean ± SEM of 20 individual p16-responsive cells; in B, D, and E traces are the mean ± SEM of 16 regions of an entire field of view. (F) Representative images of Fura-2 loaded murine split-open collecting ducts demonstrating identification of V-ATPase expressing ICs. As these are split-open tubules viewed from above, V-ATPase stain can be used to identify cell types (but not for subcellular localization). Magnification: 40×. (G) Calcium mobilization in principal cells following stimulation with p16 (200 μM) and then ATP (50 μM) in split-open collecting ducts. Trace is mean ± SEM of 24 cells from three collecting ducts. (H) Calcium mobilization in V-ATPase expressing ICs following stimulation with p16 and then ATP. Trace is mean ± SEM of 21 cells from 3 collecting ducts.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion

doi: 10.1073/pnas.2007620117

Figure Lengend Snippet: Gpr116 activation by exogenous synthetic agonist peptide mobilizes calcium in vitro and in split-open cortical collecting ducts. (A–E) Stimulation of heterologous murine and human Gpr116 in HEK293 cells with p16 synthetic agonist peptide (200 μM), but not with the control peptide (F3A), causes an increase in [Ca2+]i as measured by ΔF340/F380. Nontransfected control is shown in E. In A and C, traces are the mean ± SEM of 20 individual p16-responsive cells; in B, D, and E traces are the mean ± SEM of 16 regions of an entire field of view. (F) Representative images of Fura-2 loaded murine split-open collecting ducts demonstrating identification of V-ATPase expressing ICs. As these are split-open tubules viewed from above, V-ATPase stain can be used to identify cell types (but not for subcellular localization). Magnification: 40×. (G) Calcium mobilization in principal cells following stimulation with p16 (200 μM) and then ATP (50 μM) in split-open collecting ducts. Trace is mean ± SEM of 24 cells from three collecting ducts. (H) Calcium mobilization in V-ATPase expressing ICs following stimulation with p16 and then ATP. Trace is mean ± SEM of 21 cells from 3 collecting ducts.

Article Snippet: Antibodies used in the study table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene TaqMan ID Exon boundary ADGRF5 (Gpr116) Mm00685646_m1 6–7 SFTPC (SP-C) Mm00488144_m1 1–2 AQP2 Mm00437575_m1 1–2 SLC4A1 (AE1) Mm00441492_m1 3–4 ATP6V1B1 Mm00460309_m1 2–3 ATP6V0D2 Mm01222963_m1 1–2 ATP6V1G3 Mm00616840_m1 2–3 AQP6 Mm00558232_m1 1–2 CLCN5 (ClC-5) Mm00443851_m1 8–9 Open in a separate window TaqMan real-time PCR assays used

Techniques: Activation Assay, In Vitro, Control, Expressing, Staining

Targeted deletion of Gpr116 in kidney tubules results in loss of Gpr116 in collecting ducts. (A) Representative immunofluorescence images demonstrating localization of Gpr116-expressing cells among AQP2 expressing cells in WT mouse collecting ducts. (B) Representative immunofluorescence images demonstrating loss of Gpr116-expressing cells in mouse collecting ducts after targeted deletion with KSP-Cre/Lox system. (Scale bars, 20 μm.)

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion

doi: 10.1073/pnas.2007620117

Figure Lengend Snippet: Targeted deletion of Gpr116 in kidney tubules results in loss of Gpr116 in collecting ducts. (A) Representative immunofluorescence images demonstrating localization of Gpr116-expressing cells among AQP2 expressing cells in WT mouse collecting ducts. (B) Representative immunofluorescence images demonstrating loss of Gpr116-expressing cells in mouse collecting ducts after targeted deletion with KSP-Cre/Lox system. (Scale bars, 20 μm.)

Article Snippet: Antibodies used in the study table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene TaqMan ID Exon boundary ADGRF5 (Gpr116) Mm00685646_m1 6–7 SFTPC (SP-C) Mm00488144_m1 1–2 AQP2 Mm00437575_m1 1–2 SLC4A1 (AE1) Mm00441492_m1 3–4 ATP6V1B1 Mm00460309_m1 2–3 ATP6V0D2 Mm01222963_m1 1–2 ATP6V1G3 Mm00616840_m1 2–3 AQP6 Mm00558232_m1 1–2 CLCN5 (ClC-5) Mm00443851_m1 8–9 Open in a separate window TaqMan real-time PCR assays used

Techniques: Immunofluorescence, Expressing

Split-open cortical collecting ducts from kidney-specific Gpr116 KO do not contain cells that are stimulated by exogenous p16 synthetic agonist peptide. (A) Representative Fura-2 (ΔF340/F380) traces of split-open collecting ducts from WT and KO mice. Traces are mean ± SEM of all ATP-responsive cells in three split-open collecting ducts. (B) Summary data of ΔF340/F380 for all ATP-responsive cells observed in split-open collecting ducts from WT and KO mice. Data are normalized to ΔF340/F380 of WT tubules to ATP. Bars are mean ± SEM. n = 63 WT cells, 37 KO cells. Statistical analysis performed using Kruskal–Wallis test followed by Dunn’s multiple comparisons.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion

doi: 10.1073/pnas.2007620117

Figure Lengend Snippet: Split-open cortical collecting ducts from kidney-specific Gpr116 KO do not contain cells that are stimulated by exogenous p16 synthetic agonist peptide. (A) Representative Fura-2 (ΔF340/F380) traces of split-open collecting ducts from WT and KO mice. Traces are mean ± SEM of all ATP-responsive cells in three split-open collecting ducts. (B) Summary data of ΔF340/F380 for all ATP-responsive cells observed in split-open collecting ducts from WT and KO mice. Data are normalized to ΔF340/F380 of WT tubules to ATP. Bars are mean ± SEM. n = 63 WT cells, 37 KO cells. Statistical analysis performed using Kruskal–Wallis test followed by Dunn’s multiple comparisons.

Article Snippet: Antibodies used in the study table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene TaqMan ID Exon boundary ADGRF5 (Gpr116) Mm00685646_m1 6–7 SFTPC (SP-C) Mm00488144_m1 1–2 AQP2 Mm00437575_m1 1–2 SLC4A1 (AE1) Mm00441492_m1 3–4 ATP6V1B1 Mm00460309_m1 2–3 ATP6V0D2 Mm01222963_m1 1–2 ATP6V1G3 Mm00616840_m1 2–3 AQP6 Mm00558232_m1 1–2 CLCN5 (ClC-5) Mm00443851_m1 8–9 Open in a separate window TaqMan real-time PCR assays used

Techniques:

Deletion of Gpr116 in mouse collecting ducts decreases urine pH. (A–C) Twenty-four–hour urine pH, urine titrable acid, and urine ammonia of WT and KO mice with access to control water (0.5% sucrose, solid bars) or metabolic-acidosis inducing water (0.5% sucrose + 280 mM NH4Cl, hatched bars; paired samples). (D–F) Paired whole-blood samples harvested from facial vein puncture were analyzed for pH, HCO3− concentration, pCO2. For paired samples in A–F, bars are mean ± SEM. n = 15 WT mice, 9 KO mice. Statistical analysis performed using Kruskal–Wallis test followed by Dunn’s multiple comparisons. *P < 0.05 vs. treatment; †P < 0.05 vs. genotype. Urine pH: WT 0.5% sucrose vs. +280 mM NH4Cl *P = 0.04; WT 0.5% sucrose vs. KO 0.5% sucrose †P = 0.04. Blood pH: WT 0.5% sucrose vs. +280 mM NH4Cl *P = 0.001; KO 0.5% sucrose vs. +280 mM NH4Cl *P = 0.004. Blood HCO3−: WT 0.5% sucrose vs. +280 mM NH4Cl *P = 0.0001; KO 0.5% sucrose vs. +280 mM NH4Cl *P = 0.001. pCO2: WT 0.5% sucrose vs. +280 mM NH4Cl *P = 0.001; KO 0.5% sucrose vs. +280 mM NH4Cl *P = 0.04.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion

doi: 10.1073/pnas.2007620117

Figure Lengend Snippet: Deletion of Gpr116 in mouse collecting ducts decreases urine pH. (A–C) Twenty-four–hour urine pH, urine titrable acid, and urine ammonia of WT and KO mice with access to control water (0.5% sucrose, solid bars) or metabolic-acidosis inducing water (0.5% sucrose + 280 mM NH4Cl, hatched bars; paired samples). (D–F) Paired whole-blood samples harvested from facial vein puncture were analyzed for pH, HCO3− concentration, pCO2. For paired samples in A–F, bars are mean ± SEM. n = 15 WT mice, 9 KO mice. Statistical analysis performed using Kruskal–Wallis test followed by Dunn’s multiple comparisons. *P < 0.05 vs. treatment; †P < 0.05 vs. genotype. Urine pH: WT 0.5% sucrose vs. +280 mM NH4Cl *P = 0.04; WT 0.5% sucrose vs. KO 0.5% sucrose †P = 0.04. Blood pH: WT 0.5% sucrose vs. +280 mM NH4Cl *P = 0.001; KO 0.5% sucrose vs. +280 mM NH4Cl *P = 0.004. Blood HCO3−: WT 0.5% sucrose vs. +280 mM NH4Cl *P = 0.0001; KO 0.5% sucrose vs. +280 mM NH4Cl *P = 0.001. pCO2: WT 0.5% sucrose vs. +280 mM NH4Cl *P = 0.001; KO 0.5% sucrose vs. +280 mM NH4Cl *P = 0.04.

Article Snippet: Antibodies used in the study table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene TaqMan ID Exon boundary ADGRF5 (Gpr116) Mm00685646_m1 6–7 SFTPC (SP-C) Mm00488144_m1 1–2 AQP2 Mm00437575_m1 1–2 SLC4A1 (AE1) Mm00441492_m1 3–4 ATP6V1B1 Mm00460309_m1 2–3 ATP6V0D2 Mm01222963_m1 1–2 ATP6V1G3 Mm00616840_m1 2–3 AQP6 Mm00558232_m1 1–2 CLCN5 (ClC-5) Mm00443851_m1 8–9 Open in a separate window TaqMan real-time PCR assays used

Techniques: Control, Concentration Assay

Kidney-specific Gpr116 KO mice have alkaline blood and reduced pCO2 compared to WT littermates. (A–D) Whole-blood samples harvested from facial vein puncture demonstrate increased blood pH from KO mice, a trend toward increased blood HCO3−, and significantly reduced pCO2. TCO2 is not statistically different, but shows a trend toward increased values in KO samples (due to increased HCO3− in those samples). TCO2 was calculated as the sum of pCO2 (in mM) and HCO3−. Bars are mean ± SEM. n = 39 WT mice, 30 KO mice. Statistical analysis performed using Mann–Whitney test. *P < 0.05. Blood pH: WT vs. KO *P = 0.002; blood HCO3−: WT vs. KO P = 0.06; pCO2: WT vs. KO *P = 0.04. TCO2: WT vs. KO P = 0.06.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion

doi: 10.1073/pnas.2007620117

Figure Lengend Snippet: Kidney-specific Gpr116 KO mice have alkaline blood and reduced pCO2 compared to WT littermates. (A–D) Whole-blood samples harvested from facial vein puncture demonstrate increased blood pH from KO mice, a trend toward increased blood HCO3−, and significantly reduced pCO2. TCO2 is not statistically different, but shows a trend toward increased values in KO samples (due to increased HCO3− in those samples). TCO2 was calculated as the sum of pCO2 (in mM) and HCO3−. Bars are mean ± SEM. n = 39 WT mice, 30 KO mice. Statistical analysis performed using Mann–Whitney test. *P < 0.05. Blood pH: WT vs. KO *P = 0.002; blood HCO3−: WT vs. KO P = 0.06; pCO2: WT vs. KO *P = 0.04. TCO2: WT vs. KO P = 0.06.

Article Snippet: Antibodies used in the study table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene TaqMan ID Exon boundary ADGRF5 (Gpr116) Mm00685646_m1 6–7 SFTPC (SP-C) Mm00488144_m1 1–2 AQP2 Mm00437575_m1 1–2 SLC4A1 (AE1) Mm00441492_m1 3–4 ATP6V1B1 Mm00460309_m1 2–3 ATP6V0D2 Mm01222963_m1 1–2 ATP6V1G3 Mm00616840_m1 2–3 AQP6 Mm00558232_m1 1–2 CLCN5 (ClC-5) Mm00443851_m1 8–9 Open in a separate window TaqMan real-time PCR assays used

Techniques: MANN-WHITNEY

Kidney-specific Gpr116 KO mice have increased accumulation of V-ATPase at the apical membrane of A-ICs. Representative transmission electron micrographs reveal the subcellular localization of V-ATPase by immunogold labeling. (A) Gold particles (black dots) labeling V-ATPase are localized to subapical vesicles in A-ICs from WT mice. (B) Induction of a metabolic acidosis with the addition of NH4Cl to the drinking water causes translocation of V-ATPase to the apical membrane. Numerous microplicae are visible on the surface of the A-IC. (C) KO mice accumulate gold particles at the apical membrane of A-ICs and have visible microplicae. (D) Addition of NH4Cl to the drinking water induces growth of microplicae in KO mice. Images are representative of n = 3 kidneys per group. (Scale bars, 500 nm.) (E) Quantification of A-IC apical membrane length normalized to the cell width. (F) Quantification of gold particle density per unit length of membrane. For E and F, n = 21 cells WT 0.5% sucrose, n = 26 cells WT NH4Cl, n = 17 KO 0.5% sucrose, n = 25 cells KO NH4Cl. Statistical analysis performed using Kruskal–Wallis test followed by Dunn’s multiple comparisons. *P < 0.05 vs. treatment; †P < 0.05 vs. genotype. Apical membrane length: WT 0.5% sucrose vs. +280 mM NH4Cl *P < 0.0001; KO 0.5% sucrose vs. +280 mM NH4Cl *P = 0.005. Apical gold particles: WT 0.5% sucrose vs. +280 mM NH4Cl *P < 0.0001; WT 0.5% sucrose vs. KO 0.5% sucrose †P = 0.007.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion

doi: 10.1073/pnas.2007620117

Figure Lengend Snippet: Kidney-specific Gpr116 KO mice have increased accumulation of V-ATPase at the apical membrane of A-ICs. Representative transmission electron micrographs reveal the subcellular localization of V-ATPase by immunogold labeling. (A) Gold particles (black dots) labeling V-ATPase are localized to subapical vesicles in A-ICs from WT mice. (B) Induction of a metabolic acidosis with the addition of NH4Cl to the drinking water causes translocation of V-ATPase to the apical membrane. Numerous microplicae are visible on the surface of the A-IC. (C) KO mice accumulate gold particles at the apical membrane of A-ICs and have visible microplicae. (D) Addition of NH4Cl to the drinking water induces growth of microplicae in KO mice. Images are representative of n = 3 kidneys per group. (Scale bars, 500 nm.) (E) Quantification of A-IC apical membrane length normalized to the cell width. (F) Quantification of gold particle density per unit length of membrane. For E and F, n = 21 cells WT 0.5% sucrose, n = 26 cells WT NH4Cl, n = 17 KO 0.5% sucrose, n = 25 cells KO NH4Cl. Statistical analysis performed using Kruskal–Wallis test followed by Dunn’s multiple comparisons. *P < 0.05 vs. treatment; †P < 0.05 vs. genotype. Apical membrane length: WT 0.5% sucrose vs. +280 mM NH4Cl *P < 0.0001; KO 0.5% sucrose vs. +280 mM NH4Cl *P = 0.005. Apical gold particles: WT 0.5% sucrose vs. +280 mM NH4Cl *P < 0.0001; WT 0.5% sucrose vs. KO 0.5% sucrose †P = 0.007.

Article Snippet: Antibodies used in the study table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene TaqMan ID Exon boundary ADGRF5 (Gpr116) Mm00685646_m1 6–7 SFTPC (SP-C) Mm00488144_m1 1–2 AQP2 Mm00437575_m1 1–2 SLC4A1 (AE1) Mm00441492_m1 3–4 ATP6V1B1 Mm00460309_m1 2–3 ATP6V0D2 Mm01222963_m1 1–2 ATP6V1G3 Mm00616840_m1 2–3 AQP6 Mm00558232_m1 1–2 CLCN5 (ClC-5) Mm00443851_m1 8–9 Open in a separate window TaqMan real-time PCR assays used

Techniques: Membrane, Transmission Assay, Labeling, Translocation Assay

Gpr116 activation in A-ICs inhibits pHi recovery. (A) Representative pseudocolor images (blue, acidic; red, alkali) of intracellular pH in a split opened collecting duct loaded with pH-sensitive dye BCECF at the baseline (1), upon application of 40 mM NH4Cl (2), immediately after NH4Cl removal (3), and recovery toward the baseline pHi values (4). Confocal micrograph of the same split-opened CD probed with anti-AQP2 (pseudocolor red) is shown on the right. Examples of AQP2− ICs are depicted with white arrows. Nuclear DAPI staining is shown in pseudocolor blue. Magnification: 40×. (B) Summary graph comparing the time course of pHi changes in control (black) and p16 pretreated (100 µM for 40 min, red) ICs. Trace shows mean ± SEM for 65 control cells and 69 p16-treated cells. Each experimental condition is a summary from four collecting ducts from four different mice. Application of the NH4Cl pulse is designated by the black bar above the trace. The time points shown in A are marked as 1 to 4. (C) Summary graph of H+ extrusion rate from ICs from the control and after pretreatment with p16 shown in B. The rate was calculated as a linear slope of pHi recovery after 40 mM NH4Cl application. Statistical analysis performed using Mann–Whitney test. *P < 0.05. Control vs. p16 *P < 0.0001.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion

doi: 10.1073/pnas.2007620117

Figure Lengend Snippet: Gpr116 activation in A-ICs inhibits pHi recovery. (A) Representative pseudocolor images (blue, acidic; red, alkali) of intracellular pH in a split opened collecting duct loaded with pH-sensitive dye BCECF at the baseline (1), upon application of 40 mM NH4Cl (2), immediately after NH4Cl removal (3), and recovery toward the baseline pHi values (4). Confocal micrograph of the same split-opened CD probed with anti-AQP2 (pseudocolor red) is shown on the right. Examples of AQP2− ICs are depicted with white arrows. Nuclear DAPI staining is shown in pseudocolor blue. Magnification: 40×. (B) Summary graph comparing the time course of pHi changes in control (black) and p16 pretreated (100 µM for 40 min, red) ICs. Trace shows mean ± SEM for 65 control cells and 69 p16-treated cells. Each experimental condition is a summary from four collecting ducts from four different mice. Application of the NH4Cl pulse is designated by the black bar above the trace. The time points shown in A are marked as 1 to 4. (C) Summary graph of H+ extrusion rate from ICs from the control and after pretreatment with p16 shown in B. The rate was calculated as a linear slope of pHi recovery after 40 mM NH4Cl application. Statistical analysis performed using Mann–Whitney test. *P < 0.05. Control vs. p16 *P < 0.0001.

Article Snippet: Antibodies used in the study table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene TaqMan ID Exon boundary ADGRF5 (Gpr116) Mm00685646_m1 6–7 SFTPC (SP-C) Mm00488144_m1 1–2 AQP2 Mm00437575_m1 1–2 SLC4A1 (AE1) Mm00441492_m1 3–4 ATP6V1B1 Mm00460309_m1 2–3 ATP6V0D2 Mm01222963_m1 1–2 ATP6V1G3 Mm00616840_m1 2–3 AQP6 Mm00558232_m1 1–2 CLCN5 (ClC-5) Mm00443851_m1 8–9 Open in a separate window TaqMan real-time PCR assays used

Techniques: Activation Assay, Staining, Control, MANN-WHITNEY

Working model of Gpr116 function in A-IC from WT and KO mice. (A) In WT mice, Gpr116 is expressed on the apical membrane of A-ICs. Activation of the receptor leads to an increase in [Ca2+]i and possibly Rho GTPases (48). We hypothesize that Gpr116 acts to decrease surface accumulation of V-ATPase (red arrow) by counteracting the effects of agents, such as aldosterone and adenosine (31, 34), which promote increased surface density of proton pumps. (B) In the absence of Gpr116, there is no counter to the up-regulatory pathways, leading to accumulation of V-ATPase at the apical membrane of A-ICs. This results in increased pumping of protons into the lumen and a decrease to urine pH. By Le Chantelier’s principle, the constant depletion of cytosolic protons causes more CO2 to diffuse into the cell and combine with H2O, producing carbonic acid and ultimately more HCO3− and H+, leading to increased HCO3− reabsorption across the basolateral membrane.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion

doi: 10.1073/pnas.2007620117

Figure Lengend Snippet: Working model of Gpr116 function in A-IC from WT and KO mice. (A) In WT mice, Gpr116 is expressed on the apical membrane of A-ICs. Activation of the receptor leads to an increase in [Ca2+]i and possibly Rho GTPases (48). We hypothesize that Gpr116 acts to decrease surface accumulation of V-ATPase (red arrow) by counteracting the effects of agents, such as aldosterone and adenosine (31, 34), which promote increased surface density of proton pumps. (B) In the absence of Gpr116, there is no counter to the up-regulatory pathways, leading to accumulation of V-ATPase at the apical membrane of A-ICs. This results in increased pumping of protons into the lumen and a decrease to urine pH. By Le Chantelier’s principle, the constant depletion of cytosolic protons causes more CO2 to diffuse into the cell and combine with H2O, producing carbonic acid and ultimately more HCO3− and H+, leading to increased HCO3− reabsorption across the basolateral membrane.

Article Snippet: Antibodies used in the study table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene TaqMan ID Exon boundary ADGRF5 (Gpr116) Mm00685646_m1 6–7 SFTPC (SP-C) Mm00488144_m1 1–2 AQP2 Mm00437575_m1 1–2 SLC4A1 (AE1) Mm00441492_m1 3–4 ATP6V1B1 Mm00460309_m1 2–3 ATP6V0D2 Mm01222963_m1 1–2 ATP6V1G3 Mm00616840_m1 2–3 AQP6 Mm00558232_m1 1–2 CLCN5 (ClC-5) Mm00443851_m1 8–9 Open in a separate window TaqMan real-time PCR assays used

Techniques: Membrane, Activation Assay

TaqMan real-time PCR assays used

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion

doi: 10.1073/pnas.2007620117

Figure Lengend Snippet: TaqMan real-time PCR assays used

Article Snippet: Antibodies used in the study table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene TaqMan ID Exon boundary ADGRF5 (Gpr116) Mm00685646_m1 6–7 SFTPC (SP-C) Mm00488144_m1 1–2 AQP2 Mm00437575_m1 1–2 SLC4A1 (AE1) Mm00441492_m1 3–4 ATP6V1B1 Mm00460309_m1 2–3 ATP6V0D2 Mm01222963_m1 1–2 ATP6V1G3 Mm00616840_m1 2–3 AQP6 Mm00558232_m1 1–2 CLCN5 (ClC-5) Mm00443851_m1 8–9 Open in a separate window TaqMan real-time PCR assays used

Techniques: Real-time Polymerase Chain Reaction

AhR expression and localization in the TME of bladder, colorectal, esophageal, head and neck, and non-small cell lung cancers. (A) Scheme of the workflow used for generating AhR expression data from five FFPE TMA slides: NSCLC (non-small cell lung cancer, N = 98), HNSCC (head and neck squamous cell carcinoma, N = 80), CRC (colorectal cancer, N = 97), EC (esophageal cancer, N = 190), and BLCA (bladder cancer, N = 48). Prior to cell segmentation and tissue segmentation using the deep-learning inForm algorithm, five TMA slides were stained with six antibodies, DAPI, and anti-AhR, -CD68, -CD4, -CD8, -Pan-CK, and -FoxP3, using Vectra Polaris for mIHC image generation. The resulting data were manipulated to perform image cytometry for phenotyping and AhR expression analysis. (B) Representative mIHC image of the region of interest stained with six antibodies: DAPI for nucleus, Pan-CK for cancer/epithelial cells, CD4 and CD8 for T cells, CD68 for macrophages, and FoxP3 for Tregs. (C) Heatmap summarizing the AhR expression in five different tissue samples: NSCLC, HNSCC, colorectal cancer, esophageal cancer, and bladder cancer. The resulting data were clustered based on the AhR expression in the cytosol or nucleus of cancer/epithelial cells, T cells, macrophages, and Tregs. (D) Pie charts depicting the AhR-positive (AhR + ) and -negative (AhR - ) cancer cells (left) and average percentage of AhR-expressing cancer cells (right) in the cytosol and nucleus of NSCLC, HNSCC, CRC (colorectal cancer), EC (esophageal cancer), and BLCA (bladder cancer) cells.

Journal: Frontiers in Immunology

Article Title: Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types

doi: 10.3389/fimmu.2024.1330228

Figure Lengend Snippet: AhR expression and localization in the TME of bladder, colorectal, esophageal, head and neck, and non-small cell lung cancers. (A) Scheme of the workflow used for generating AhR expression data from five FFPE TMA slides: NSCLC (non-small cell lung cancer, N = 98), HNSCC (head and neck squamous cell carcinoma, N = 80), CRC (colorectal cancer, N = 97), EC (esophageal cancer, N = 190), and BLCA (bladder cancer, N = 48). Prior to cell segmentation and tissue segmentation using the deep-learning inForm algorithm, five TMA slides were stained with six antibodies, DAPI, and anti-AhR, -CD68, -CD4, -CD8, -Pan-CK, and -FoxP3, using Vectra Polaris for mIHC image generation. The resulting data were manipulated to perform image cytometry for phenotyping and AhR expression analysis. (B) Representative mIHC image of the region of interest stained with six antibodies: DAPI for nucleus, Pan-CK for cancer/epithelial cells, CD4 and CD8 for T cells, CD68 for macrophages, and FoxP3 for Tregs. (C) Heatmap summarizing the AhR expression in five different tissue samples: NSCLC, HNSCC, colorectal cancer, esophageal cancer, and bladder cancer. The resulting data were clustered based on the AhR expression in the cytosol or nucleus of cancer/epithelial cells, T cells, macrophages, and Tregs. (D) Pie charts depicting the AhR-positive (AhR + ) and -negative (AhR - ) cancer cells (left) and average percentage of AhR-expressing cancer cells (right) in the cytosol and nucleus of NSCLC, HNSCC, CRC (colorectal cancer), EC (esophageal cancer), and BLCA (bladder cancer) cells.

Article Snippet: Multiple staining rounds were performed using the following anti-human antibodies: anti-AhR (cat: LS-C783005-100; LS Biosciences), anti-CD68 (cat: 76437; Cell Signaling Technology), anti-CD4 (cat: ab181724; Abcam), anti-CD8 (cat: CD8-4B11-L-CE; Leica Biosystems), anti-FoxP3 (cat: 98377; Cell Signaling Technology, anti-PanCK (cat: AE1/AE3-601-L-CE; Leica Biosystems).

Techniques: Expressing, Staining, Cytometry